Instituto Universitario de Tecnologías Biomédicas
Instituto de investigación
Instituto de Investigación Sanitaria Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Valdecilla (7)
2024
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211
-
Worldwide distribution of genetic factors related to severity of COVID-19 infection
Annals of Human Biology, Vol. 51, Núm. 1
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Nature, Vol. 617, Núm. 7962, pp. 764-768
-
Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19
Translational Psychiatry, Vol. 13, Núm. 1
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806